Direct antiviral agents for HCV infection and hepatocellular carcinoma: facts and FADs

The advent of directly acting antivirals (DAA) has determined a showy change in the management of hepatitis C virus (HCV) infection, the most common cause of hepatocellular carcinoma (HCC) in many countries. It was demonstrated that the achievement of sustained virologic response (SVR) with interfer...

Descripción completa

Detalles Bibliográficos
Autores principales: Serio, Ilaria, Napoli, Lucia, Leoni, Simona, Piscaglia, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798330/
https://www.ncbi.nlm.nih.gov/pubmed/35117103
http://dx.doi.org/10.21037/tcr.2019.04.01

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798330/
https://www.ncbi.nlm.nih.gov/pubmed/35117103
http://dx.doi.org/10.21037/tcr.2019.04.01

Ejemplares similares